Cargando…
Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case
Vaccines to prevent the impact of SARS-CoV-2 are now available, including for patients with autoimmune diseases. However, there is no information about how inflammatory bowel disease (IBD) treatment could impact the cellular and humoral immune responses. This study evaluated SARS-CoV-2-specific humo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620698/ https://www.ncbi.nlm.nih.gov/pubmed/34834950 http://dx.doi.org/10.3390/v13112143 |
_version_ | 1784605283182444544 |
---|---|
author | Melgaço, Fabiana Gil Azamor, Tamiris Villar, Livia Melo Ano Bom, Ana Paula Dinis Melgaço, Juliana Gil |
author_facet | Melgaço, Fabiana Gil Azamor, Tamiris Villar, Livia Melo Ano Bom, Ana Paula Dinis Melgaço, Juliana Gil |
author_sort | Melgaço, Fabiana Gil |
collection | PubMed |
description | Vaccines to prevent the impact of SARS-CoV-2 are now available, including for patients with autoimmune diseases. However, there is no information about how inflammatory bowel disease (IBD) treatment could impact the cellular and humoral immune responses. This study evaluated SARS-CoV-2-specific humoral and cellular responses after vaccination with a two-dose schedule in a Crohn’s disease patient treated with Infliximab (10 mg/kg); we included comparisons with a monozygotic twin. The results showed that the Crohn’s disease’s twin (twin 2) had no antibody detection and reduced activation of CD4+ T cell responses, unlike the twin without the autoimmune disease (twin 1). Twin 2 developed antigen-specific central memory CD8+ T-cells and IFNγ production after the second dose of COVID-19 vaccination, similar to twin 1. These findings elucidated the role of T-cell immunity after COVID-19 immunization on IBD patients despite the lack of antibody production. Finally, our observation supports the consensus recommendation for IBD patients to receive COVID-19 vaccines. |
format | Online Article Text |
id | pubmed-8620698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86206982021-11-27 Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case Melgaço, Fabiana Gil Azamor, Tamiris Villar, Livia Melo Ano Bom, Ana Paula Dinis Melgaço, Juliana Gil Viruses Communication Vaccines to prevent the impact of SARS-CoV-2 are now available, including for patients with autoimmune diseases. However, there is no information about how inflammatory bowel disease (IBD) treatment could impact the cellular and humoral immune responses. This study evaluated SARS-CoV-2-specific humoral and cellular responses after vaccination with a two-dose schedule in a Crohn’s disease patient treated with Infliximab (10 mg/kg); we included comparisons with a monozygotic twin. The results showed that the Crohn’s disease’s twin (twin 2) had no antibody detection and reduced activation of CD4+ T cell responses, unlike the twin without the autoimmune disease (twin 1). Twin 2 developed antigen-specific central memory CD8+ T-cells and IFNγ production after the second dose of COVID-19 vaccination, similar to twin 1. These findings elucidated the role of T-cell immunity after COVID-19 immunization on IBD patients despite the lack of antibody production. Finally, our observation supports the consensus recommendation for IBD patients to receive COVID-19 vaccines. MDPI 2021-10-24 /pmc/articles/PMC8620698/ /pubmed/34834950 http://dx.doi.org/10.3390/v13112143 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Melgaço, Fabiana Gil Azamor, Tamiris Villar, Livia Melo Ano Bom, Ana Paula Dinis Melgaço, Juliana Gil Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case |
title | Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case |
title_full | Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case |
title_fullStr | Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case |
title_full_unstemmed | Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case |
title_short | Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case |
title_sort | impairment of cd4+ t and memory b cell responses but normal memory cd8+t-cell activation on crohn’s disease after covid-19 vaccination: a twin case |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620698/ https://www.ncbi.nlm.nih.gov/pubmed/34834950 http://dx.doi.org/10.3390/v13112143 |
work_keys_str_mv | AT melgacofabianagil impairmentofcd4tandmemorybcellresponsesbutnormalmemorycd8tcellactivationoncrohnsdiseaseaftercovid19vaccinationatwincase AT azamortamiris impairmentofcd4tandmemorybcellresponsesbutnormalmemorycd8tcellactivationoncrohnsdiseaseaftercovid19vaccinationatwincase AT villarliviamelo impairmentofcd4tandmemorybcellresponsesbutnormalmemorycd8tcellactivationoncrohnsdiseaseaftercovid19vaccinationatwincase AT anobomanapauladinis impairmentofcd4tandmemorybcellresponsesbutnormalmemorycd8tcellactivationoncrohnsdiseaseaftercovid19vaccinationatwincase AT melgacojulianagil impairmentofcd4tandmemorybcellresponsesbutnormalmemorycd8tcellactivationoncrohnsdiseaseaftercovid19vaccinationatwincase |